Gerresheimer AG (SWX:GXI)
Switzerland
· Delayed Price · Currency is CHF | Market Cap | 762.47M |
| Revenue (ttm) | 2.11B |
| Net Income (ttm) | 21.85M |
| Shares Out | n/a |
| EPS (ttm) | 0.63 |
| PE Ratio | 34.89 |
| Forward PE | 8.73 |
| Dividend | 0.04 (0.19%) |
| Ex-Dividend Date | Jun 6, 2025 |
| Volume | n/a |
| Average Volume | 96 |
| Open | n/a |
| Previous Close | 20.10 |
| Day's Range | n/a |
| 52-Week Range | 16.16 - 75.60 |
| Beta | n/a |
| RSI | 69.06 |
| Earnings Date | Apr 16, 2026 |
About Gerresheimer AG
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery progra... [Read more]
Financial Performance
In fiscal year 2024, Gerresheimer AG's revenue was 2.04 billion, an increase of 2.28% compared to the previous year's 1.99 billion. Earnings were 109.72 million, a decrease of -5.52%.
Financial numbers in EURNews
Gerresheimer rejects takeover bid from US packing firm Silgan, say sources
German medical packaging maker Gerresheimer has rejected a takeover bid from its U.S. rival Silgan , three sources familiar with the situation told Reuters.
EQS-Adhoc: Gerresheimer AG: Creditors agree to extend the due date for submitting the audited 2025 annual and consolidated financial statements
EQS-Ad-hoc: Gerresheimer AG / Key word(s): Significant contracts Gerresheimer AG: Creditors agree to extend the due date for submitting the audited 2025 annual and consolidated financial statements 15...
EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Gerresheimer AG Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributi...
Gerresheimer delays 2025 results release to June, stock to be removed from SDAX
Gerresheimer on Tuesday again deferred the release of 2025 financial statements to June, citing a probe into its business deals, a delay that is now set to cost the German medical products maker ...
Gerresheimer appoints Uwe Röhrhoff as new interim CEO
Medical equipment maker Gerresheimer said on Tuesday it had appointed Uwe Röhrhoff as interim CEO, effective November 1, 2025. He succeeds Dietmar Siemssen, who will step down as CEO by mutual agreeme...
Gerresheimer finds 2024 revenue-recognition issues after external probe
Medical equipment maker Gerresheimer said it has obtained the initial findings from an investigation by an external law firm into the recognition of revenue and profit from bill-and-hold agreements in...
Gerresheimer AG Earnings Call Transcript: Q3 2025
Q3 and nine-month results were below expectations, with organic revenue and EBITDA declines driven by weak cosmetics and oral liquids markets. Guidance was revised downward, a transformation program was launched, and liquidity remains strong with no covenant breaches.
Gerresheimer's shares fall 11% after another outlook cut
Shares in Gerresheimer fell 11% on Thursday, a day after the German packaging and medical equipment maker cut its 2025 guidance for the third time this year.
Gerresheimer AG Earnings Call Transcript: Q3 2025
Q3 and the first nine months of 2025 were below expectations, with organic revenue and EBITDA both declining year-over-year. Guidance was revised downward, with a projected organic revenue decline of -4% to -2% and an adjusted EBITDA margin of 18.5%-19%.
Gerresheimer cuts 2025 outlook again as Q3 disappoints
German packaging and medical equipment maker Gerresheimer cut its 2025 guidance again on Wednesday, now expecting organic revenues to decline between 2-4% as third quarter results fell below expectati...
Gerresheimer shares tank as financial regulator suspects accounting flaws
Shares in medical equipment maker Gerresheimer plunged as much as 38% on Wednesday after Germany's financial regulator said it was investigating suspected accounting rule violations.
Gerresheimer CFO resigns unexpectedly, successor to take over from September
Gerresheimer Chief Financial Officer Bernd Metzner has resigned from his role and will leave the company on August 31, the German packaging and medical equipment maker said on Friday.
Activist investor wants review at Gerresheimer after taking stake
Active Ownership, a major shareholder in Gerresheimer , said on Thursday it saw major potential for value creation at the German packaging and medical equipment specialist and called for a strategic r...
Gerresheimer shares rise on plan to sell moulded glass business
Shares of German packaging and medical equipment maker Gerresheimer jumped around 4% in early trading on Tuesday after the company announced plans to sell its moulded glass business late on Monday.
Gerresheimer AG Transcript: Investor Update
Net debt to EBITDA and free cash flow trends were discussed, with expectations for stabilization. Operational focus includes drug delivery systems, plastics, and primary packaging glass, alongside ongoing partnerships and governance initiatives.
Gerresheimer calls a halt to discussions on potential takeover
German packaging and medical equipment maker Gerresheimer has ended discussions on a potential sale of the company, it said on Wednesday evening.
Gerresheimer AG Earnings Call Transcript: Q2 2025
Q2 2025 saw strong reported growth from the Bormioli Pharma acquisition, but organic growth was modest due to ongoing weakness in cosmetics and oral liquids. Guidance for 2025 was lowered, with a focus on margin, cash flow, and deleveraging, while high-value solutions and biologics remain key growth drivers.
Gerresheimer cuts its 2025 revenue outlook for second time
German packaging and medical equipment maker Gerresheimer cut its revenue guidance for 2025 for a second time on Thursday, seeing continued weak demand in the cosmetic and oral liquids markets.
AVI Calls for Changes at Gerresheimer
LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) has sent an open letter to the Supervisory Board of Gerresheimer AG (“Gerresheimer”) calling for it to make changes to its financial leadership. ...
UK fund Asset Value Investor calls for changes at Gerresheimer
London-based investment fund Asset Value Investors has asked German medical packaging maker Gerresheimer to take steps to restore its market value, it said on Thursday.
Gerresheimer AG Earnings Call Transcript: Q2 2025
2025 guidance was revised down due to weak H1 demand in cosmetics and oral liquids, despite Bormioli Pharma's positive impact. Organic revenue growth is now expected at 1%-2% with a 20% adjusted EBITDA margin, and a stronger H2 is anticipated, led by GLP-1 and new launches.
Gerresheimer cuts guidance for 2025 citing weak demand
German packaging and medical equipment maker Gerresheimer cut its guidance for 2025 on Monday, citing continued weak demand in the cosmetics sector and a decline in demand for containment solutions fo...
Gerresheimer AG Earnings Call Transcript: Q1 2025
Q1 2025 saw reported revenue and adjusted EBITDA growth due to the Bormioli Pharma acquisition, but organic results declined from phasing and weak cosmetics. Guidance for 2025 is reaffirmed, with organic growth and margin expansion expected, driven by plant restarts, new product ramp-ups, and strong order intake, especially in high-value solutions.
Gerresheimer's first-quarter results hit by low demand in moulded glass
German packaging and medical equipment maker Gerresheimer reported a lower organic core profit for the first quarter on Friday, hit by continued lower demand in moulded glass and shift in syringe reve...
KKR drops out of consortium seeking Gerresheimer takeover, Bloomberg News reports
KKR has abandoned a private equity consortium discussing a takeover of Gerresheimer AG , Bloomberg News reported on Thursday, citing people familiar with the matter.